LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis <it>in vitro</it>

<p>Abstract</p> <p>Background</p> <p>Relapse due to chemoresistant residual disease is a major cause of death in acute myelogenous leukemia (AML). The present study was undertaken to elucidate the molecular mechanisms of chemoresistance by comparing differential gene ex...

Full description

Bibliographic Details
Main Authors: Pendino Frederic, Gjertsen Bjørn, Kjarland Endre, Myklebust Line M, Huang Tien-sheng, Bruserud Øystein, Døskeland Stein, Lillehaug Johan R
Format: Article
Language:English
Published: BMC 2007-04-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/6/1/31